Advertisement
Review Article| Volume 38, ISSUE 1, P1-15, January 2019

Download started.

Ok

Corticosteroids and Hyaluronic Acid Injections

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Sports Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Loeser R.F.
        • Goldring S.R.
        • Scanzello C.R.
        • et al.
        OA: a disease of the joint as an organ.
        Arthritis Rheum. 2012; 64: 1697-1707
        • Malemud C.J.
        • Islam N.
        • Haqqi T.M.
        Pathophysiological mechanisms in OA lead to novel therapeutic strategies.
        Cells Tissues Organs. 2003; 174: 34-48
        • Wang Y.
        • Hall S.
        • Hanna F.
        • et al.
        Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in OA of the knee: a two-year single-blind clinical trial.
        BMC Musculoskelet Disord. 2011; 12: 195
        • Neustadt D.H.
        Intra-articular injections for OA of the knee.
        Cleve Clin J Med. 2006; 73 (901–4, 906–11): 897-898
        • Conaghan P.G.
        • Dickson J.
        • Grant R.L.
        Care and management of OA in adults: summary of NICE guidance.
        BMJ. 2008; 336: 502-503
        • Ayhan E.
        • Kesmezacar H.
        • Akgun I.
        Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee OA.
        World J Orthop. 2014; 5
        • MacMahon P.J.
        • Eustace S.J.
        • Kavanagh E.C.
        Injectable corticosteroid and local anesthetic preparations: a review for radiologists.
        Radiology. 2009; 252: 647-661
        • Malemud C.J.
        Cytokines as therapeutic targets for OA.
        BioDrugs. 2004; 18: 23-35
        • Uthman I.
        • Raynauld J.-P.
        • Haraoui B.
        Intra-articular therapy in OA.
        Postgrad Med J. 2003; 79: 449-453
        • Raynauld J.-P.
        • Buckland-Wright C.
        • Ward R.
        • et al.
        Safety and efficacy of long-term intraarticular steroid injections in OA of the knee: a randomized, double-blind, placebo-controlled trial.
        Arthritis Rheum. 2003; 48: 370-377
        • Pelletier J.P.
        • Martel-Pelletier J.
        • Cloutier J.M.
        • et al.
        Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections.
        Arthritis Rheum. 1987; 30: 541-548
        • Cole B.J.
        • Schumacher R.H.J.
        Injectable corticosteroids in modern practice.
        J Am Acad Orthop Surg. 2005; 13: 37-46
        • Habib G.S.
        Systemic effects of intra-articular corticosteroids.
        Clin Rheumatol. 2009; 28: 749-756
        • Makkar J.K.
        • Singh P.M.
        • Jain D.
        • et al.
        Particulate vs non-particulate steroids for transforaminal epidural steroid injections: systematic review and meta-analysis of the current literature.
        Pain Physician. 2016; 19: 327-340
        • Derby R.
        • Lee S.H.
        • Date E.S.
        • et al.
        Size and aggregation of corticosteroids used for epidural injections.
        Pain Med. 2008; 9: 227-234
        • Kaufman M.B.
        Pharmaceutical approval update.
        P T. 2017; 42: 733-755
        • Bodick N.
        • Lufkin J.
        • Willwerth C.
        • et al.
        An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with OA of the knee: a randomized clinical trial.
        J Bone Joint Surg Am. 2015; 97: 877-888
        • Bellamy N.
        • Campbell J.
        • Welch V.
        • et al.
        Intraarticular corticosteroid for treatment of OA of the knee.
        Cochrane Database Syst Rev. 2006; (CD005328)
        • Jüni P.
        • Hari R.
        • Rutjes A.W.S.
        • et al.
        Intra-articular corticosteroid for knee OA.
        Cochrane Database Syst Rev. 2015; (CD005328)
        • Gaffney K.
        • Ledingham J.
        • Perry J.D.
        Intra-articular triamcinolone hexacetonide in knee OA: factors influencing the clinical response.
        Ann Rheum Dis. 1995; 54: 379-381
        • Godwin M.
        • Dawes M.
        Intra-articular steroid injections for painful knees. Systematic review with meta-analysis.
        Can Fam Physician. 2004; 50: 241-248
        • Chao J.
        • Wu C.
        • Sun B.
        • et al.
        Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee OA.
        J Rheumatol. 2010; 37: 650-655
        • Cheng O.T.
        • Souzdalnitski D.
        • Vrooman B.
        • et al.
        Evidence-based knee injections for the management of arthritis.
        Pain Med. 2012; 13: 740-753
        • Pekarek B.
        • Osher L.
        • Buck S.
        • et al.
        Intra-articular corticosteroid injections: a critical literature review with up-to-date findings.
        Foot (Edinb). 2011; 21: 66-70
        • Legré-Boyer V.
        Viscosupplementation: Techniques, indications, results.
        Orthop Traumatol Surg Res. 2015; 101: S101-S108
        • Weitoft T.
        • Uddenfeldt P.
        Importance of synovial fluid aspiration when injecting intra-articular corticosteroids.
        Ann Rheum Dis. 2000; 59: 233-235
        • Farkas B.
        • Kvell K.
        • Czömpöly T.
        • et al.
        Increased chondrocyte death after steroid and local anesthetic combination.
        Clin Orthop Relat Res. 2010; 468: 3112-3120
        • Karpie J.C.
        • Chu C.R.
        Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro.
        Am J Sports Med. 2007; 35: 1621-1627
        • Nakazawa F.
        • Matsuno H.
        • Yudoh K.
        • et al.
        Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures.
        Clin Exp Rheumatol. 2002; 20: 773-781
        • McAlindon T.E.
        • LaValley M.P.
        • Harvey W.F.
        • et al.
        Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee OA: a randomized clinical trial.
        JAMA. 2017; 317: 1967-1975
        • Eckstein F.
        • Boudreau R.M.
        • Wang Z.
        • et al.
        Trajectory of cartilage loss within 4 years of knee replacement – a nested case–control study from the OA initiative.
        Osteoarthritis Cartilage. 2014; 22: 1542-1549
        • Braun H.J.
        • Wilcox-Fogel N.
        • Kim H.J.
        • et al.
        The effect of local anesthetic and corticosteroid combinations on chondrocyte viability.
        Knee Surg Sports Traumatol Arthrosc. 2012; 20: 1689-1695
        • Chu C.R.
        • Izzo N.J.
        • Papas N.E.
        • et al.
        In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes.
        Arthroscopy. 2006; 22: 693-699
        • Shortt C.P.
        • Morrison W.B.
        • Roberts C.C.
        • et al.
        Shoulder, hip, and knee arthrography needle placement using fluoroscopic guidance: practice patterns of musculoskeletal radiologists in North America.
        Skeletal Radiol. 2009; 38: 377-385
        • Schumacher H.R.
        Aspiration and injection therapies for joints.
        Arthritis Care Res. 2003; 49: 413-420
        • J Monseau A.
        • Singh Nizran P.
        Common injections in musculoskeletal medicine.
        Prim Care. 2013; 40: 987-1000
        • Bashir M.A.
        • Ray R.
        • Sarda P.
        • et al.
        Determination of a safe INR for joint injections in patients taking warfarin.
        Ann R Coll Surg Engl. 2015; 97: 589-591
        • Okere K.
        • Jones M.C.
        A case of skin hypopigmentation secondary to a corticosteroid injection.
        South Med J. 2006; 99: 1393-1394
        • Loarte Pasquel E.P.
        • Cabal García A.A.
        Cutaneous atrophy and hypopigmentation secondary to intra-articular corticosteroid injection.
        Semergen. 2014; 40 ([in Spanish]): e61-e63
        • Lazarevic M.B.
        • Skosey J.L.
        • Djordjevic-Denic G.
        • et al.
        Reduction of cortisol levels after single intra-articular and intramuscular steroid injection.
        Am J Med. 1995; 99: 370-373
        • Xu C.
        • Peng H.
        • Li R.
        • et al.
        Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: a matched retrospective cohort analysis.
        Semin Arthritis Rheum. 2018; 47: 911-916
        • Black D.M.
        • Filak A.T.
        Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection.
        J Fam Pract. 1989; 28: 462-463
        • Brown G.A.
        AAOS clinical practice guideline: treatment of OA of the knee: evidence-based guideline, 2nd Edition.
        J Am Acad Orthop Surg. 2013; 21: 577-579
        • Hochberg M.C.
        American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in OA of the hand, hip, and knee.
        Arthritis Care Res (Hoboken). 2012; 64: 465-474
        • Wehling P.
        • Evans C.
        • Wehling J.
        • et al.
        Effectiveness of intra-articular therapies in OA: a literature review.
        Ther Adv Musculoskelet Dis. 2017; 9: 183-196
        • McCabe P.S.
        • Maricar N.
        • Parkes M.J.
        • et al.
        The efficacy of intra-articular steroids in hip OA: a systematic review.
        Osteoarthritis Cartilage. 2016; 24: 1509-1517
        • Gross C.
        • Dhawan A.
        • Harwood D.
        • et al.
        Glenohumeral joint injections: a review.
        Sports Health. 2013; 5: 153-159
        • Kroon F.P.B.
        • Rubio R.
        • Schoones J.W.
        • et al.
        Intra-articular therapies in the treatment of hand OA: a systematic literature review.
        Drugs Aging. 2016; 33: 119-133
        • Waddell D.D.
        Viscosupplementation with hyaluronans for OA of the knee.
        Drugs Aging. 2007; 24: 629-642
        • Bellamy N.
        • Campbell J.
        • Robinson V.A.
        • et al.
        Viscosupplementation for the treatment of OA of the knee.
        Cochrane Database Syst Rev. 2005; (CD005321)
        • Shah R.P.
        • Stambough J.B.
        • Fenty M.
        • et al.
        T1rho magnetic resonance imaging at 3T detects knee cartilage changes after viscosupplementation.
        Orthopedics. 2015; 38: e604-e610
        • Bowman S.
        • Awad M.E.
        • Hamrick M.W.
        • et al.
        Recent advances in hyaluronic acid based therapy for OA.
        Clin Transl Med. 2018; 7: 6
        • Altman R.D.
        • Bedi A.
        • Karlsson J.
        • et al.
        Product differences in intra-articular hyaluronic acids for OA of the knee.
        Am J Sports Med. 2016; 44: 2158-2165
        • Colen S.
        • van den Bekerom M.P.
        • Mulier M.
        • et al.
        Hyaluronic acid in the treatment of knee OA: a systematic review and meta-analysis with emphasis on the efficacy of different products.
        BioDrugs. 2012; 26: 257-268
        • Ricci M.
        Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee OA.
        Musculoskelet Surg. 2017; 101: 45-49
        • Newberry S.J.
        • Fitzgerald J.D.
        • Maglione M.A.
        • et al.
        Systematic review for effectiveness of hyaluronic acid in the treatment of severe degenerative joint disease (DJD) of the knee.
        Agency for Healthcare Research and Quality (US), Rockville (MD)2015
        • Gigis I.
        • Fotiadis E.
        • Nenopoulos A.
        • et al.
        Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee OA.
        Hippokratia. 2016; 20: 26-31
        • Waddell D.D.
        • Bricker D.C.
        Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV OA.
        J Manag Care Pharm. 2007; 13: 113-121
        • Adams M.E.
        The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of OA of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
        Osteoarthr Cartil. 1995; 3: 213-225
        • Bannuru R.R.
        • Schmid C.H.
        • Kent D.M.
        • et al.
        Comparative effectiveness of pharmacologic interventions for knee OA: a systematic review and network meta-analysis.
        Ann Intern Med. 2015; 162: 46-54
        • Petrella R.
        • Cogliano A.
        • Decaria J.
        Comparison of avian and nonavian hyaluronic acid in OA of the knee.
        Orthop Res Rev. 2010; 2: 5-9
        • Danilkowicz R.
        • Robinson M.
        • Steffes M.
        • et al.
        Inflammatory pseudoseptic reaction to synvisc-one injection requiring diagnostic arthroscopy.
        J Case Rep Images Orthop Rheum. 2017; 2: 7-11
        • Kroesen S.
        • Schmid W.
        • Theiler R.
        Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc).
        Clin Rheumatol. 2000; 19: 147-149
        • Jevsevar D.S.
        Treatment of OA of the knee: evidence-based guideline, 2nd Edition.
        J Am Acad Orthop Surg. 2013; 21: 571-576
        • Trojian T.H.
        • Concoff A.L.
        • Joy S.M.
        • et al.
        AMSSM scientific statement concerning viscosupplementation injections for knee OA: importance for individual patient outcomes.
        Br J Sports Med. 2016; 50: 84-92
        • Migliore A.
        • Anichini S.
        Intra-articular therapy in hip OA.
        Clin Cases Miner Bone Metab. 2017; 14: 179-181
        • Lieberman J.R.
        • Engstrom S.M.
        • Solovyova O.
        • et al.
        Is intra-articular hyaluronic acid effective in treating OA of the hip joint?.
        J Arthroplasty. 2015; 30: 507-511
        • Chang K.-V.
        • Hsiao M.-Y.
        • Chen W.-S.
        • et al.
        Effectiveness of intra-articular hyaluronic acid for ankle OA treatment: a systematic review and meta-analysis.
        Arch Phys Med Rehabil. 2013; 94: 951-960
        • Papalia R.
        • Albo E.
        • Russo F.
        • et al.
        The use of hyaluronic acid in the treatment of ankle OA: a review of the evidence.
        J Biol Regul Homeost Agents. 2017; 31: 91-102
        • Witteveen A.G.
        • Giannini S.
        • Guido G.
        • et al.
        A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) OA.
        Foot Ankle Surg. 2008; 14: 145-152
        • Silverstein E.
        • Leger R.
        • Shea K.P.
        The use of intra-articular hylan G-F 20 in the treatment of symptomatic OA of the shoulder: a preliminary study.
        Am J Sports Med. 2007; 35: 979-985
        • Di Giacomo G.
        • de Gasperis N.
        Hyaluronic acid intra-articular injections in patients affected by moderate to severe glenohumeral OA: a prospective randomized study.
        Joints. 2017; 5: 138-142
        • Kwon Y.W.
        • Eisenberg G.
        • Zuckerman J.D.
        Sodium hyaluronate for the treatment of chronic shoulder pain associated with glenohumeral OA: a multicenter, randomized, double-blind, placebo-controlled trial.
        J Shoulder Elbow Surg. 2013; 22: 584-594
        • Blaine T.
        • Moskowitz R.
        • Udell J.
        • et al.
        Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study.
        J Bone Joint Surg Am. 2008; 90: 970-979
        • Hoeber S.
        • Aly A.-R.
        • Ashworth N.
        • et al.
        Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: a systematic review and meta-analysis.
        Br J Sports Med. 2016; 50: 392-396
        • Jackson D.W.
        • Evans N.A.
        • Thomas B.M.
        Accuracy of needle placement into the intra-articular space of the knee.
        J Bone Joint Surg Am. 2002; 84-A: 1522-1527
        • Hussein M.
        An accurate full-flexion anterolateral portal for needle placement in the knee joint with dry OA.
        J Am Acad Orthop Surg. 2017; 25: e131-e137